+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cell Lysis/Cell Fractionation Market Research Report by Product, by Application, by Cell Type, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 5324595
  • Report
  • July 2021
  • Region: Global
  • 199 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Cell Lysis/Cell Fractionation Market will Grow to USD 4,282.79 Million by 2026, at a CAGR of 8.36%

FEATURED COMPANIES

  • Agilent Technologies
  • Biovision
  • Covaris
  • Norgen Biotek Corp.
  • Promega Corporation
  • Qsonica
  • MORE
The Global Cell Lysis/Cell Fractionation Market size was estimated at USD 2,645.38 Million in 2020 and expected to reach USD 2,857.61 Million in 2021, at a Compound Annual Growth Rate (CAGR) 8.36% to reach USD 4,282.79 Million by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Cell Lysis/Cell Fractionation to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the Cell Lysis/Cell Fractionation Market was studied across Consumables and Instruments. The Consumables is further studied across Beads, Disposables, and Reagents & Kits. The Instruments is further studied across Homogenizers and Sonicators.
  • Based on End-user, the Cell Lysis/Cell Fractionation Market was studied across Biopharmaceutical & Biotechnology Companies and Research Laboratories & Institutes.
  • Based on Application, the Cell Lysis/Cell Fractionation Market was studied across Nucleic Acid Purification & Isolation and Protein Purification & Isolation.
  • Based on Cell Type, the Cell Lysis/Cell Fractionation Market was studied across Mammalian Cells and Microbial Cells.
  • Based on Region, the Cell Lysis/Cell Fractionation Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cell Lysis/Cell Fractionation Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Cell Lysis/Cell Fractionation Market, including Agilent Technologies, Beckman Coulter, Becton, Dickinson and Company, Bio-Rad Laboratories, Biovision, Cell Signaling Technology, Claremont Biosolutions, Covaris, G-Biosciences (Geno Technology), Labfreez Instruments Group, Merck, Microfluidics International Corporation, Miltenyi Biotec, Norgen Biotek Corp., Nzytech, Parr Instrument Company, Promega Corporation, Promocell, Qiagen, Qsonica, Roche Diagnostics, Stemcell Technologies, Takara Bio, and Thermo Fisher Scientific.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Cell Lysis/Cell Fractionation Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cell Lysis/Cell Fractionation Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cell Lysis/Cell Fractionation Market?
4. What is the competitive strategic window for opportunities in the Global Cell Lysis/Cell Fractionation Market?
5. What are the technology trends and regulatory frameworks in the Global Cell Lysis/Cell Fractionation Market?
6. What is the market share of the leading vendors in the Global Cell Lysis/Cell Fractionation Market?
7. What modes and strategic moves are considered suitable for entering the Global Cell Lysis/Cell Fractionation Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Agilent Technologies
  • Biovision
  • Covaris
  • Norgen Biotek Corp.
  • Promega Corporation
  • Qsonica
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. End-user Outlook
3.5. Application Outlook
3.6. Cell Type Outlook
3.7. Region Outlook
3.8. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Expanding healthcare, life sciences, and pharmaceutical industries research and developmental activities in countless fields
5.1.1.2. Increasing government funding for research
5.1.1.3. Increasing cases of diseases and diagnostics
5.1.2. Restraints
5.1.2.1. High cost of cell-based equipments and researches
5.1.2.2. Shortage of trained personnel
5.1.3. Opportunities
5.1.3.1. Growing focus on personalized medicine, and the expansion of biopharmaceutical and biotechnology industries
5.1.3.2. Growing prevalence of diseases such as HIV/AIDS and cancer
5.1.4. Challenges
5.1.4.1. Survival of small players and addition of new technological advancement routinely
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Cell Lysis/Cell Fractionation Market, by Product
6.1. Introduction
6.2. Consumables
6.2.1. Beads
6.2.2. Disposables
6.2.3. Reagents & Kits
6.3. Instruments
6.3.1. Homogenizers
6.3.2. Sonicators

7. Cell Lysis/Cell Fractionation Market, by End-user
7.1. Introduction
7.2. Biopharmaceutical & Biotechnology Companies
7.3. Research Laboratories & Institutes

8. Cell Lysis/Cell Fractionation Market, by Application
8.1. Introduction
8.2. Nucleic Acid Purification & Isolation
8.3. Protein Purification & Isolation

9. Cell Lysis/Cell Fractionation Market, by Cell Type
9.1. Introduction
9.2. Mammalian Cells
9.3. Microbial Cells

10. Americas Cell Lysis/Cell Fractionation Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Cell Lysis/Cell Fractionation Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Thailand

12. Europe, Middle East & Africa Cell Lysis/Cell Fractionation Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. Agilent Technologies
14.2. Beckman Coulter
14.3. Becton, Dickinson and Company
14.4. Bio-Rad Laboratories
14.5. Biovision
14.6. Cell Signaling Technology
14.7. Claremont Biosolutions
14.8. Covaris
14.9. G-Biosciences (Geno Technology)
14.10. Labfreez Instruments Group
14.11. Merck
14.12. Microfluidics International Corporation
14.13. Miltenyi Biotec
14.14. Norgen Biotek Corp.
14.15. Nzytech
14.16. Parr Instrument Company
14.17. Promega Corporation
14.18. Promocell
14.19. Qiagen
14.20. Qsonica
14.21. Roche Diagnostics
14.22. Stemcell Technologies
14.23. Takara Bio
14.24. Thermo Fisher Scientific

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 3. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2020 (USD MILLION)
FIGURE 4. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 5. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2020 (USD MILLION)
FIGURE 6. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY REGION, 2020 (USD MILLION)
FIGURE 7. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 8. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET: MARKET DYNAMICS
FIGURE 9. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 10. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 11. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2026
FIGURE 13. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2026 (USD MILLION)
FIGURE 14. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 15. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY BEADS, 2018-2026 (USD MILLION)
FIGURE 16. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY BEADS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 17. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY DISPOSABLES, 2018-2026 (USD MILLION)
FIGURE 18. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY DISPOSABLES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 19. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY REAGENTS & KITS, 2018-2026 (USD MILLION)
FIGURE 20. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 21. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2026 (USD MILLION)
FIGURE 22. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 23. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY HOMOGENIZERS, 2018-2026 (USD MILLION)
FIGURE 24. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY HOMOGENIZERS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 25. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY SONICATORS, 2018-2026 (USD MILLION)
FIGURE 26. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY SONICATORS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 27. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2020 VS 2026 (%)
FIGURE 28. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2020 VS 2026 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2026
FIGURE 30. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2018-2026 (USD MILLION)
FIGURE 31. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 32. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY RESEARCH LABORATORIES & INSTITUTES, 2018-2026 (USD MILLION)
FIGURE 33. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 34. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 35. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 36. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2026
FIGURE 37. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY NUCLEIC ACID PURIFICATION & ISOLATION, 2018-2026 (USD MILLION)
FIGURE 38. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY NUCLEIC ACID PURIFICATION & ISOLATION, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 39. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PROTEIN PURIFICATION & ISOLATION, 2018-2026 (USD MILLION)
FIGURE 40. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PROTEIN PURIFICATION & ISOLATION, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 41. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2020 VS 2026 (%)
FIGURE 42. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 43. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2026
FIGURE 44. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY MAMMALIAN CELLS, 2018-2026 (USD MILLION)
FIGURE 45. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY MAMMALIAN CELLS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 46. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY MICROBIAL CELLS, 2018-2026 (USD MILLION)
FIGURE 47. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY MICROBIAL CELLS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 48. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 49. ARGENTINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 50. BRAZIL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 51. CANADA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 52. MEXICO CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 53. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 54. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 55. AUSTRALIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 56. CHINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 57. INDIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 58. INDONESIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 59. JAPAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 60. MALAYSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 61. PHILIPPINES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 62. SINGAPORE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 63. SOUTH KOREA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 64. THAILAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 65. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 66. FRANCE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 67. GERMANY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 68. ITALY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 69. NETHERLANDS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 70. QATAR CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 71. RUSSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 72. SAUDI ARABIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 73. SOUTH AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 74. SPAIN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 75. UNITED ARAB EMIRATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 76. UNITED KINGDOM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 77. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET: FPNV POSITIONING MATRIX
FIGURE 78. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 79. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY BEADS, BY REGION, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY DISPOSABLES, BY REGION, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY HOMOGENIZERS, BY REGION, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY SONICATORS, BY REGION, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 16. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY NUCLEIC ACID PURIFICATION & ISOLATION, BY REGION, 2018-2026 (USD MILLION)
TABLE 17. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PROTEIN PURIFICATION & ISOLATION, BY REGION, 2018-2026 (USD MILLION)
TABLE 18. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2026 (USD MILLION)
TABLE 19. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY MAMMALIAN CELLS, BY REGION, 2018-2026 (USD MILLION)
TABLE 20. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY MICROBIAL CELLS, BY REGION, 2018-2026 (USD MILLION)
TABLE 21. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 22. ARGENTINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 23. BRAZIL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 24. CANADA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 25. MEXICO CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 26. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 27. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 28. AUSTRALIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 29. CHINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 30. INDIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 31. INDONESIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 32. JAPAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. MALAYSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. PHILIPPINES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. SINGAPORE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. SOUTH KOREA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. THAILAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. FRANCE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 40. GERMANY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 41. ITALY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 42. NETHERLANDS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 43. QATAR CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 44. RUSSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 45. SAUDI ARABIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 46. SOUTH AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 47. SPAIN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 48. UNITED ARAB EMIRATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 49. UNITED KINGDOM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 50. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET: SCORES
TABLE 51. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET: BUSINESS STRATEGY
TABLE 52. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET: PRODUCT SATISFACTION
TABLE 53. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET: RANKING
TABLE 54. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 55. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET: MERGER & ACQUISITION
TABLE 56. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 57. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 58. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET: INVESTMENT & FUNDING
TABLE 59. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 60. GLOBAL CELL LYSIS/CELL FRACTIONATION MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Agilent Technologies
  • Beckman Coulter
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • Biovision
  • Cell Signaling Technology
  • Claremont Biosolutions
  • Covaris
  • G-Biosciences (Geno Technology)
  • Labfreez Instruments Group
  • Merck
  • Microfluidics International Corporation
  • Miltenyi Biotec
  • Norgen Biotek Corp.
  • Nzytech
  • Parr Instrument Company
  • Promega Corporation
  • Promocell
  • Qiagen
  • Qsonica
  • Roche Diagnostics
  • Stemcell Technologies
  • Takara Bio
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll